Visible Jaundice Threshold
Jaundice becomes clinically visible when serum bilirubin levels exceed 2.5 to 3 mg/dL in adults 1, with the most recent high-quality evidence from 2025 confirming this threshold at approximately 3 mg/dL 2.
Bilirubin Threshold by Population
Adults
- Clinical detection occurs at serum bilirubin >3 mg/dL 2
- The 2016 systematic review establishes the range of 2.5-3 mg/dL as the threshold where yellowing of eyes and skin becomes apparent 1
- This represents the point where bilirubin deposits sufficiently in skin and mucous membranes to produce visible discoloration
Neonates
- Jaundice becomes visible at 5-7 mg/dL in newborns 3
- This higher threshold reflects different skin characteristics and bilirubin distribution in neonatal tissue
- Approximately 60% of newborns develop visible jaundice 3
Clinical Significance
The visibility threshold is distinct from pathologic thresholds:
- Visible jaundice at 3 mg/dL does NOT automatically indicate serious disease - it simply means hyperbilirubinemia is present
- The underlying cause determines clinical significance, not just the presence of visible jaundice 2
- Once jaundice is detected, fractionated bilirubin (conjugated vs unconjugated) guides diagnostic workup 4, 2
Common Pitfall
Do not confuse the visibility threshold with treatment thresholds. The 3 mg/dL level where jaundice becomes visible is far below levels requiring urgent intervention in adults. The visibility threshold simply triggers diagnostic evaluation, not automatic treatment 2, 1.